UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 307

Sortiert nach

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.397-406

2018

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer

European journal of cancer (1990), 2011-11, Vol.47 (17), p.2537-2545

2011

Link zum Volltext

Verfügbarkeit prüfen

Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer

Radiology. Imaging cancer, 2023-03, Vol.5 (2), p.e220022-e220022

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-11-05: The cardo-oncology concerns of combining tamoxifen and ribociclib based on the TEEL trial

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-11-05

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

Breast cancer research and treatment, 2021-02, Vol.185 (3), p.759-771

2021

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of indoximod in patients with advanced malignancies

Oncotarget, 2016-04, Vol.7 (16), p.22928-22938

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular testing and the pathologist’s role in clinical trials of breast cancer

Clinical breast cancer, 2016-06, Vol.16 (3), p.166-179

2016

Link zum Volltext

Verfügbarkeit prüfen

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors

Breast cancer research : BCR, 2013-11, Vol.15 (6), p.R110-R110, Article R110

2013

Link zum Volltext

Verfügbarkeit prüfen

Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data

Breast cancer targets and therapy, 2020-01, Vol.12, p.251-258

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of the Pregnant Patient with Breast Cancer

Southern medical journal (Birmingham, Ala.), 2017-10, Vol.110 (10), p.627

2017

Link zum Volltext

Verfügbarkeit prüfen

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

Future oncology (London, England), 2017-02, Vol.13 (4), p.307-320

2017

Link zum Volltext

Verfügbarkeit prüfen

Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between

American Society of Clinical Oncology educational book, 2023-06, Vol.43 (43), p.e390464-e390464

2023

Link zum Volltext

Verfügbarkeit prüfen

A Phase 1 Dose Escalation Study of Eribulin in Combination with Weekly Carboplatin for the Treatment of Metastatic Breast Cancer

Cancer research journal (New York, N.Y. Print), 2021, Vol.9 (3), p.171

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures

Contemporary clinical trials, 2020-04, Vol.91, p.105976-105976, Article 105976

2020

Link zum Volltext

Verfügbarkeit prüfen

Fertility and reproductive considerations in premenopausal patients with breast cancer

Cancer control, 2010-07, Vol.17 (3), p.162-172

2010

Link zum Volltext

Verfügbarkeit prüfen

Beta-catenin expression patterns in matched pre- and post-neoadjuvant chemotherapy-resistant breast cancer

Annals of clinical and laboratory science, 2015, Vol.45 (1), p.10-16

2015

Link zum Volltext

Verfügbarkeit prüfen

Regulation of mitosis and taxane response by Daxx and Rassf1

Oncogene, 2012-01, Vol.31 (1), p.13-26

2012

Link zum Volltext

Verfügbarkeit prüfen

TRLS-06. PHASE 1 EXPANSION STUDY OF IRINOTECAN LIPOSOME INJECTION (nal-IRI) IN PATIENTS WITH METASTATIC BREAST CANCER (mBC): FINDINGS FROM THE COHORT WITH ACTIVE BRAIN METASTASIS (BM)

Neuro-oncology advances, 2019-08, Vol.1 (Supplement_1), p.i9-i9

2019

Link zum Volltext

Verfügbarkeit prüfen

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in

Future oncology (London, England), 2017-02, Vol.13 (4), p.307-320

2017

Link zum Volltext

Verfügbarkeit prüfen

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia

Leukemia & lymphoma, 2007-01, Vol.48 (8), p.1561-1568

2007

Link zum Volltext

Verfügbarkeit prüfen

Time to Nadir Peripheral White Blood Cell Count (WBC) and Absolute WBC Nadir Value Following Induction Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML) Predicts Survival

Blood, 2004-11, Vol.104 (11), p.1074-1074

2004

Link zum Volltext

Verfügbarkeit prüfen

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML)

Blood, 2004-11, Vol.104 (11), p.3140-3140

2004

Link zum Volltext

Verfügbarkeit prüfen

Colonoscopy evaluation after short-term anti-tuberculosis treatment in nonspecific ulcers on the ileocecal area

World journal of gastroenterology : WJG, 2008-08, Vol.14 (32), p.5051-5058

2008

Link zum Volltext

Verfügbarkeit prüfen

Ph Ib/II study of BKM120 plus trastuzumab in patients with trastuzumab-resistant HER2+ advanced breast cancer

2012

Link zum Volltext

Verfügbarkeit prüfen

Mast cell tryptase‐PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis

Parasite immunology, 2021-08, Vol.43 (8), p.e12868-n/a

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 307

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(296)

Publikationsform

Sprache

Englisch
(253)
Koreanisch
(53)
Japanisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer

Pretherapy Ferumoxytol-enhanced MRI to Predict Response to Liposomal Irinotecan in Metastatic Breast Cancer

Abstract P5-11-05: The cardo-oncology concerns of combining tamoxifen and ribociclib based on the TEEL trial

Phase I study of liposomal irinotecan in patients with metastatic breast cancer: findings from the expansion phase

A phase I study of indoximod in patients with advanced malignancies

Molecular testing and the pathologist’s role in clinical trials of breast cancer

A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors

Alpelisib in the Treatment of Breast Cancer: A Short Review on the Emerging Clinical Data

Treatment of the Pregnant Patient with Breast Cancer

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale

Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between

A Phase 1 Dose Escalation Study of Eribulin in Combination with Weekly Carboplatin for the Treatment of Metastatic Breast Cancer

A randomized placebo-controlled trial of bupropion for Cancer-related fatigue: Study design and procedures

Fertility and reproductive considerations in premenopausal patients with breast cancer

Beta-catenin expression patterns in matched pre- and post-neoadjuvant chemotherapy-resistant breast cancer

Regulation of mitosis and taxane response by Daxx and Rassf1

TRLS-06. PHASE 1 EXPANSION STUDY OF IRINOTECAN LIPOSOME INJECTION (nal-IRI) IN PATIENTS WITH METASTATIC BREAST CANCER (mBC): FINDINGS FROM THE COHORT WITH ACTIVE BRAIN METASTASIS (BM)

A randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in

White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia

Time to Nadir Peripheral White Blood Cell Count (WBC) and Absolute WBC Nadir Value Following Induction Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML) Predicts Survival

The Relationship between Weekend Admissions and Outcome in Older Adults with Acute Myelogenous Leukemia (AML)

Colonoscopy evaluation after short-term anti-tuberculosis treatment in nonspecific ulcers on the ileocecal area

Ph Ib/II study of BKM120 plus trastuzumab in patients with trastuzumab-resistant HER2+ advanced breast cancer

Mast cell tryptase‐PAR2 pathway in proliferation of prostatic stromal cells reacted with Trichomonas vaginalis

Suchergebnisse filtern